These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26078206)

  • 41. The DNA-Dialogue: A Broad Societal Dialogue About Human Germline Genome Editing in the Netherlands.
    van Baalen S; Gouman J; Houtman D; Vijlbrief B; Riedijk S; Verhoef P
    CRISPR J; 2021 Aug; 4(4):616-625. PubMed ID: 34406039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPRing into the woods.
    Tsai CJ; Xue LJ
    GM Crops Food; 2015; 6(4):206-15. PubMed ID: 26357840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why Human Germline Editing is More Problematic than Selecting Between Embryos: Ethically Considering Intergenerational Relationships.
    Rehmann-Sutter C
    New Bioeth; 2018 Apr; 24(1):9-25. PubMed ID: 29529985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does human genome editing reinforce or violate human dignity?
    Segers S; Mertes H
    Bioethics; 2020 Jan; 34(1):33-40. PubMed ID: 31222790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No time to waste--the ethical challenges created by CRISPR: CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells.
    Caplan AL; Parent B; Shen M; Plunkett C
    EMBO Rep; 2015 Nov; 16(11):1421-6. PubMed ID: 26450575
    [No Abstract]   [Full Text] [Related]  

  • 47. CRISPR-Based Methods for Caenorhabditis elegans Genome Engineering.
    Dickinson DJ; Goldstein B
    Genetics; 2016 Mar; 202(3):885-901. PubMed ID: 26953268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common marmoset as a new model animal for neuroscience research and genome editing technology.
    Kishi N; Sato K; Sasaki E; Okano H
    Dev Growth Differ; 2014 Jan; 56(1):53-62. PubMed ID: 24387631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome Editing in Mouse Spermatogonial Stem Cell Lines Using TALEN and Double-Nicking CRISPR/Cas9.
    Sato T; Sakuma T; Yokonishi T; Katagiri K; Kamimura S; Ogonuki N; Ogura A; Yamamoto T; Ogawa T
    Stem Cell Reports; 2015 Jul; 5(1):75-82. PubMed ID: 26095606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction.
    Andorno R; Baylis F; Darnovsky M; Dickenson D; Haker H; Hasson K; Lowthorp L; Annas GJ; Bourgain C; Drabiak K; Graumann S; Grüber K; Kaiser M; King D; Kollek R; MacKellar C; Nie JB; Obasogie OK; Tyebally Fang M; Werner-Felmayer G; Zuscinova J
    Trends Biotechnol; 2020 Apr; 38(4):351-354. PubMed ID: 32014274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential impact of human mitochondrial replacement on global policy regarding germline gene modification.
    Ishii T
    Reprod Biomed Online; 2014 Aug; 29(2):150-5. PubMed ID: 24832374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precise Genome Editing of Drosophila with CRISPR RNA-Guided Cas9.
    Gratz SJ; Harrison MM; Wildonger J; O'Connor-Giles KM
    Methods Mol Biol; 2015; 1311():335-48. PubMed ID: 25981484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Germline edits: Trust ethics review process.
    Savulescu J; Gyngell C; Douglas T
    Nature; 2015 Apr; 520(7549):623. PubMed ID: 25925471
    [No Abstract]   [Full Text] [Related]  

  • 54. Editing mammalian genomes: ethical considerations.
    Greenfield A
    Mamm Genome; 2017 Aug; 28(7-8):388-393. PubMed ID: 28653171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.
    Shao M; Xu TR; Chen CS
    Dongwuxue Yanjiu; 2016 Jul; 37(4):191-204. PubMed ID: 27469250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome editing with engineered nucleases in plants.
    Osakabe Y; Osakabe K
    Plant Cell Physiol; 2015 Mar; 56(3):389-400. PubMed ID: 25416289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germline gene editing and the precautionary principle.
    Koplin JJ; Gyngell C; Savulescu J
    Bioethics; 2020 Jan; 34(1):49-59. PubMed ID: 31247677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The illusion of control in germline-engineering policy.
    König H
    Nat Biotechnol; 2017 Jun; 35(6):502-506. PubMed ID: 28591117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.